BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 35777613)

  • 1. The effect of COVID 19 vaccination on kidney recipients.
    Marzieh L; Elahe P; Habib R; Maryam P; Arefeh J; Elnaz E; Sanaz D
    Transpl Immunol; 2022 Oct; 74():101658. PubMed ID: 35777613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 After Vaccination in Lung Transplant Recipients: Real-Life Data.
    Türkkan S; Çelik Başaran F; Şahin MF; Beyoğlu MA; Yılmaz E; Yazıcıoğlu A; Yiğit Özay H; Bindal M; Tezer Tekçe Y; Yekeler E
    Exp Clin Transplant; 2023 Mar; 21(3):265-271. PubMed ID: 35867010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
    Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
    Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV; Sinopharm) and Short-Term Clinical Outcomes in Vaccinated Solid Organ Transplant Recipients: A Prospective Cohort Study.
    Shafiekhani M; Mirjalili M; Gholami S; Vatankhah P; Roozbeh J; Mehrdad G; Haem E; Zare Z; Jalali SS; Golshan M; Nikeghbalian S; Chamanpara P; Shamsaeefar A; Moghadami M; Nikoupour H; Malekhosseini SA; Sohrevardi SM; Jamialahmadi T; Sahebkar A; Geramizadeh B
    Adv Exp Med Biol; 2023; 1412():357-374. PubMed ID: 37378777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
    Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
    Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximab.
    Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
    Int J Urol; 2022 Nov; 29(11):1279-1286. PubMed ID: 35863901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients.
    Demir E; Dheir H; Safak S; Serra Artan A; Sipahi S; Turkmen A
    Vaccine; 2022 May; 40(24):3313-3319. PubMed ID: 35504784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications and Efficacy of Sinopharm Vaccine among Liver and Kidney Transplantation.
    Aliakbarian M; Khodashahi R; Sabbagh MG; Rezayat KA; Khodashahi M; Khaleghi E; Moghaddam MD; Razmkhah B; Nazar MN; Sheikhi N
    Curr Drug Saf; 2023; 18(1):15-22. PubMed ID: 35249504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
    Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
    BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.
    Grupper A; Katchman E; Ben-Yehoyada M; Rabinowich L; Schwartz D; Schwartz IF; Shashar M; Halperin T; Turner D; Goykhman Y; Shibolet O; Levy S; Houri I; Baruch R; Katchman H
    Clin Transplant; 2021 Dec; 35(12):e14478. PubMed ID: 34506644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant Recipients.
    Peters LL; Raymer DS; Pal JD; Ambardekar AV
    JAMA Cardiol; 2022 Jun; 7(6):651-654. PubMed ID: 35475896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of SARS-CoV-2 infection among vaccinated individuals: A hospital-based study.
    Govindapala D; Jayasekara P; Rajramanan R; de Silva N
    Ceylon Med J; 2022 Dec; 67(4):143-150. PubMed ID: 38421276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland.
    Bell S; Campbell J; Lambourg E; Watters C; O'Neil M; Almond A; Buck K; Carr EJ; Clark L; Cousland Z; Findlay M; Joss N; Metcalfe W; Petrie M; Spalding E; Traynor JP; Sanu V; Thomson P; Methven S; Mark PB
    J Am Soc Nephrol; 2022 Apr; 33(4):677-686. PubMed ID: 35110363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond prevention: Unveiling the benefits of triple vaccination on COVID-19 severity and resource utilization in solid organ transplant recipients.
    Zhang JR; Johnson JC; Preble RG; Mujtaba M; Lea AS; Stevenson HL; Kueht M
    Transpl Immunol; 2024 Jun; 84():102048. PubMed ID: 38641149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre.
    Chukwu CA; Mahmood K; Elmakki S; Gorton J; Kalra PA; Poulikakos D; Middleton R
    PLoS One; 2022; 17(3):e0265130. PubMed ID: 35271655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
    Mazuecos A; Villanego F; Zarraga S; López V; Oppenheimer F; Llinàs-Mallol L; Hernández AM; Rivas A; Ruiz-Fuentes MC; Toapanta NG; Jiménez C; Cabello S; Beneyto I; Aladrén MJ; Rodríguez-Benot A; Canal C; Molina M; Pérez-Flores I; Saura IM; Gavela E; Franco A; Lorenzo I; Galeano C; Tabernero G; Pérez-Tamajón L; Martín-Moreno PL; Fernández-Girón F; Siverio O; Labrador PJ; De Arriba G; Simal F; Cruzado L; Moina I; Alcalde G; Sánchez-Álvarez E; Pascual J; Crespo M;
    Transplantation; 2022 Jul; 106(7):1430-1439. PubMed ID: 35384924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and Effects of Vaccination on Sars-Cov-2 Omicron Infection in Kidney Transplant Recipients.
    Chiu HF; Tsai SF; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2023 May; 55(4):820-823. PubMed ID: 37208223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of SARS-CoV-2 Vaccine in Kidney Transplant Recipients: A Cross-Sectional Study in Korea.
    Song SH; Chung KY; Jee Y; Chung HS; Kim K; Minn D; Kim SK
    J Korean Med Sci; 2023 Feb; 38(5):e22. PubMed ID: 36747360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.